Digital Health Ecosystem report from Galen Growth and FINN Partners magnifies insights for the “Digital Health Ecosystem – Asia Pacific Report”
Digital health, data-driven market intelligence company, Galen Growth and FINN Partners, a global integrated marketing services agency have created the “DIGITAL HEALTH ECOSYSTEM – ASIA PACIFIC, 2022 Year-End Report.” The report examines major shifts and outlines best practices in investment strategies comparing Asia to the world scene examining 250 million data points over 14,000 ventures.
The digital health sector has grown significantly during the past decade. The investment by the global financial and corporate markets rose from $2 billion in 2011 to $44 billion in 2021. Moreover, tremendous investment poured into digital health in the shadow of the pandemic. However, in the past year, investors have been more selective in their decisions.
But total investment dollars in digital health took a steep dive in 2022; however, the picture looks significantly different on a region-to-region basis. While Asia-Pacific saw an investment decline in 2022, the Q4 trend shows a rebound worth watching and studying.
The Galen Growth experts pinpoint in a new phase of digital health investment. The shift from exuberant investment in 2020 and 2021, to a market shift that mirror previous years of strategic engagement. Private equity and business development dollars continue to flow toward the category however, directed toward specific therapeutic categories and technologies. Out of the total funding value deployed in 2022 for the region, research solutions and online marketplace clusters captured 49 per cent of total funds invested and, oncology and cardiovascular diseases were the most invested therapeutic areas.
The Galen/FINN “Digital Health Ecosystem – Asia Pacific Report” shows verified trends such as:
- Venture capital funding in Asia Pacific’s digital health industry decreased during the first three quarters of 2022 but bounced back in Q4 ending the year at $5.79B, with a YoY decrease of 41 per cent from 2021.
- Venture funding deceleration was largely due to China’s investment falling by 66 per cent YoY – the lowest since 2017, amidst strict pandemic regulations. However, Northeast Asia’s funding doubled to $1.9B, surpassing China and South Asia, which dropped by 30 per cent compared to 2021.
- Asia Pacific saw a 33 per cent YoY decrease in M&A activity, but digital health ventures accounted for 60 per cent of global acquisitions, driving industry consolidation. The slowdown in venture funding has fueled acquisitions, with only 34 per cent of Growth Stage ventures in Asia Pacific able to raise capital over the past 18 months.
- In 2023, digital health ventures faced challenges due to declining venture valuations. However, the industry’s resilience in 2022 will strengthen the venture pipeline, driving innovation and business model viability to show the value of digital health tools in improving healthcare research and delivery.
The report draws inputs from 250 million data points and more than 14,000 digital health ventures. It will be released at the March Asia Leadership Meet Summit in Singapore. With this partnership, experts from the FINN Global Digital Health Group are working with Galen Growth data and research professionals to chart the complex and often fragmented digital health landscape, emerging market trends, areas of growth and innovation, and look beyond equity funding to explore what’s expected to happen in this fast-paced sector.
FINN digital health leaders lent their perspective, analysis, and guidance to supplement the data and insights developed by the Galen Growth team to help guide stakeholders as they navigate and engage with the digital health landscape.